ADA 2024 Diabetes Technology Recap
Jul 18, 03:25 PM
This special edition episode of Diabetes Dialogue: Technology, Therapeutics, & Real-World Perspectives focuses on top highlights and updates in diabetes technology from the 84th American Diabetes Association Scientific Sessions.
In the episode, hosts Omnipod 5 and the SECURE-T2D trial, a study comparing use of simplified meal announcement vs precise carbohydrate counting with the Medtronic MiniMed 780G, and real-world data from Tandem pump users. Later in the episode, hosts discuss their experience on the conference floor getting hands-on interactions with soon to come or recently released diabetes technology showcased at the meeting, including the Sequel Twiist, Abbott’s Libre 3 Plus, and ketone monitors.
Episode Chapters
00:00 - Intro
00:37 - Episode Start
01:05 - SECURE-T2D
05:50 - Medtronic Data
08:40 - Tandem Data
16:40 - Forthcoming Diabetes Technology
17:45 - Sequel Twiist
20:45 - Libre 3 Plus
24:00 - OTC CGM
25:00 - Dexcom Upgrades
29:15 - Ketone Monitors
In the episode, hosts Omnipod 5 and the SECURE-T2D trial, a study comparing use of simplified meal announcement vs precise carbohydrate counting with the Medtronic MiniMed 780G, and real-world data from Tandem pump users. Later in the episode, hosts discuss their experience on the conference floor getting hands-on interactions with soon to come or recently released diabetes technology showcased at the meeting, including the Sequel Twiist, Abbott’s Libre 3 Plus, and ketone monitors.
Episode Chapters
00:00 - Intro
00:37 - Episode Start
01:05 - SECURE-T2D
05:50 - Medtronic Data
08:40 - Tandem Data
16:40 - Forthcoming Diabetes Technology
17:45 - Sequel Twiist
20:45 - Libre 3 Plus
24:00 - OTC CGM
25:00 - Dexcom Upgrades
29:15 - Ketone Monitors